What is the treatment for a 65-year-old female patient, 15 days post-ileostomy, presenting with hypotension, tachycardia, mild hypothermia, elevated total leukocyte count (TLC), significant proteinuria, and low serum calcium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Post-Ileostomy Patient with Hypotension, Leukocytosis, Proteinuria, and Hypocalcemia

This patient requires immediate assessment for hemodynamic stability, followed by cause-directed treatment focusing on hypovolemia from high ileostomy output, with concurrent management of hypocalcemia and investigation for infection or sepsis.

Immediate Assessment and Stabilization

Determine hemodynamic stability first - this patient with BP 100/70, pulse 104, and elevated TLC 16,000 requires immediate bedside assessment to identify if end-organ dysfunction is present (altered mental status, oliguria, chest pain), which would necessitate immediate high-acuity care 1, 2.

Perform Passive Leg Raise (PLR) Test

  • Execute PLR test to determine if hypotension is preload-responsive before reflexive fluid administration, as approximately 50% of hypotensive patients are not hypovolemic and fluid administration worsens outcomes in these cases 1, 2, 3.
  • If PLR corrects the hypotension (BP increases), proceed with fluid resuscitation 1, 3.
  • If PLR does not correct hypotension, consider vasopressor support or transfer to higher level of care 1.

Identify the Underlying Cause

  • Assess for dehydration from high ileostomy output - the most common cause of readmission (9.3%) in post-ileostomy patients is dehydration and acute kidney injury secondary to high stoma output 4, 5.
  • Check for signs of hypovolemia: tachycardia (present - pulse 104), oliguria, decreased skin turgor, and measure ileostomy output volume 2, 6.
  • Evaluate for sepsis given TLC 16,000 - obtain blood cultures, assess surgical site, examine stoma for complications, and check for intra-abdominal infection 6.
  • Measure serum lactate and obtain arterial blood gas as markers of tissue perfusion and shock severity 6.

Fluid Resuscitation Strategy

For confirmed hypovolemia (positive PLR test), administer intravenous crystalloid fluid bolus:

  • Give 250-500 mL bolus in adults using crystalloid solutions 2, 3.
  • Monitor response with vital signs, urine output, and repeat serum lactate 6.
  • Avoid excessive fluid administration - only 54% of patients with suspected hypovolemia respond to fluid bolus, and overresuscitation causes harm 1.

If Hypotension Persists Despite Fluid Resuscitation

  • Start norepinephrine at 8-12 mcg/minute for vasodilation if PLR test is negative 2, 3.
  • Consider dobutamine 2-5 mcg/kg/min if low cardiac output is suspected 2, 3.
  • Avoid phenylephrine as first-line except when tachycardia is present, as it causes reflex bradycardia that can worsen cardiac output 1, 3.

Hypocalcemia Management

Treat symptomatic hypocalcemia immediately with intravenous calcium gluconate:

  • Administer calcium gluconate 1,000-2,000 mg (10-20 mL of 10% solution) IV over 10-20 minutes 7.
  • Dilute with 5% dextrose or normal saline and infuse slowly to avoid vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmias, and cardiac arrest 7.
  • Maximum infusion rate should not exceed 200 mg/minute in adults with continuous ECG monitoring 7.
  • Measure serum calcium every 4-6 hours during intermittent infusions 7.

Critical Considerations for Calcium Administration

  • Ensure secure IV access - extravasation causes tissue necrosis, calcinosis cutis, ulceration, and secondary infection; if extravasation occurs, immediately discontinue and treat 7.
  • Hypocalcemia in post-ileostomy patients may result from malabsorption, vitamin D deficiency, or hypoalbuminemia affecting calcium binding 8.
  • Correct for albumin - significant proteinuria (++) suggests hypoalbuminemia, which lowers total calcium but may not reflect true ionized calcium status; measure ionized calcium if available 8.

Investigation for Infection/Sepsis

Given TLC 16,000, rule out infectious complications:

  • Obtain complete blood count, comprehensive metabolic panel, blood urea nitrogen, creatinine, and blood cultures 6.
  • Perform immediate 12-lead ECG to identify arrhythmias 6.
  • Consider bedside ultrasound or CT imaging to evaluate for intra-abdominal abscess, anastomotic leak, or other surgical complications 6.
  • If sepsis is confirmed, initiate broad-spectrum antibiotics immediately and follow sepsis management protocols with norepinephrine as first-line vasopressor 1, 3.

Monitoring Requirements

Continuous monitoring for at least 24 hours:

  • ECG, blood pressure, oxygen saturation, heart rate, temperature, and urine output 2, 6.
  • Measure ileostomy output volume and character 4, 5.
  • Serial serum calcium measurements every 4-6 hours during treatment 7.
  • Monitor serum electrolytes (potassium, magnesium, phosphate) and renal function 6, 7.
  • Track fluid balance with intake/output records 6.

Critical Pitfalls to Avoid

  • Do not give reflexive fluid boluses without PLR testing - this worsens outcomes in approximately 50% of patients who are not hypovolemic 1, 2, 3.
  • Never administer calcium rapidly - rates exceeding 200 mg/minute cause hypotension, bradycardia, arrhythmias, and cardiac arrest 7.
  • Avoid calcium administration in patients on digoxin without close ECG monitoring, as hypercalcemia increases digoxin toxicity and causes arrhythmias 7.
  • Do not ignore the possibility of sepsis - elevated WBC in post-operative ileostomy patients may indicate surgical site infection, anastomotic leak, or intra-abdominal abscess requiring source control 6.
  • Monitor for aluminum toxicity with prolonged calcium gluconate administration, particularly if renal impairment develops (up to 512 mcg/L aluminum content) 7.

Disposition and Follow-up

  • Transfer to ICU/HDU if patient is unstable or requires vasopressor support 1.
  • Once stabilized, address underlying causes: optimize ileostomy management, provide patient education on fluid intake, consider anti-motility agents if high output persists 4, 5.
  • Investigate cause of proteinuria once acute issues resolved - may indicate pre-renal azotemia from dehydration or underlying renal pathology 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Hypotension in Cardiac Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Symptomatic Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Journey for patients following ileostomy creation is not straightforward.

International journal of colorectal disease, 2019

Guideline

Hypotension Workup and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute renal failure and hypercalcemia.

Renal failure, 2006

Related Questions

What is the diagnosis and treatment for a female patient with impaired renal function, hypercalcemia, elevated liver enzymes, and hyperglycemia?
What is the diagnosis and treatment for a patient with hyperglycemia, hypercalcemia, and impaired renal function?
What are the differential diagnoses for an elderly lady, a heavy smoker, presenting with hypercalcemia, anemia, acute renal failure, muscle pains, and fatigue?
Are TUMS (calcium carbonate) safe for patients with impaired renal function?
What is the recommended ileostomy output to be maintained?
Can hepatic congestion due to right-sided heart failure or other cardiovascular conditions lead to abdominal pain via systemic hypoperfusion?
Can an SGLT2 (sodium-glucose cotransporter 2) inhibitor, such as empagliflozin (Empagliflozin) or canagliflozin (Canagliflozin), be initiated in a patient with type 2 diabetes and mild impaired renal function, specifically a glomerular filtration rate (GFR) of 60?
What is the initial management for a patient with bilateral pleural effusions?
What is the optimal management plan for a middle-aged female patient with a history of Attention Deficit Disorder (ADD), Hypertension (HTN), Hyperlipidemia (HLD), Takotsubo cardiomyopathy, and Coronary Artery Disease (CAD), who presents with symptoms of fatigue, shortness of breath, and chest tightness, and has a history of acute respiratory failure, Chronic Obstructive Pulmonary Disease (COPD) exacerbation, and pneumonia?
What is the recommended dose of paracetamol (acetaminophen) for pediatric patients?
What to do for a patient with tachypnea on invasive mechanical ventilation in pressure support (PS) mode?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.